Wells Fargo & Company »

Transcode Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Transcode Therapeutics shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Transcode Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Transcode Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Transcode Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $25 155 0.17
2023-09-30 $6 11 0.55
2023-06-30 $9 4 2.25

More positions owned by Wells Fargo & Company

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Ishares Tr Core S&p500 Etf Put Option (IVV)
Vanguard Index Fds Mid Cap Etf Put Option (VO)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p Ttl Stk (ITOT)
JPMorgan Chase & Co. Put Option (JPM)
Amazon Call Option (AMZN)
NVIDIA Corporation Put Option (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
UnitedHealth (UNH)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Wells Fargo & Company

Top funds holding Transcode Therapeutics

Private Capital Management

View all funds holding Transcode Therapeutics